Trusted Peptide Ranker

Featured Verification Report

Trusted Peptide Ranker · Verification Bureau · Audit Report Ref: TPR-2026-0601-HS | Rev. 3

Helix Standards

helixstandards.com · US-based · Research compounds (not for human use)

BPC-157 TB-500 Sermorelin +9 more

Verified

Audited Jun 1, 2026

Verification Checklist — 8 of 9 checks passed

COA verified — third-party labHPLC identity + purity per batch

Batch-linked documentsEach vial traceable to its lot

Claims language — cleanNo human-use or treatment language

Regulatory status disclosedResearch-only classification stated

Lab accreditation confirmedISO/IEC 17025 certified facility

Refund policy — transparentTerms publicly visible, no email gate

FDA warning letter historyNo letters on record as of audit date

Payment risk — flaggedCard processor changed Nov 2025

Shipping transparencyCarrier disclosed, tracking provided

Audit Timeline

Jun 1, 2026 — Current Audit

Full re-verification completed. 8/9 checks passed. Status: Verified.

Payment processor flag retained from prior cycle; all documentation checks clear.

Nov 14, 2025 — Interim Notice

Payment processor change logged. Bureau watch item opened.

Vendor notified. No documentation changes required.

Mar 6, 2025 — Prior Audit

Full verification passed 9/9 checks. Status: Verified.

New batch-linked COA format adopted; commended in audit notes.

Sep 12, 2024 — Initial Registration

Vendor entered the register. Preliminary document review opened.

Issued by: Trusted Peptide Ranker Verification Bureau · Not a regulatory determination · Educational only Full audit file →

Current Bureau Analysis

How a vendor earns verified status — and how fast it can lose it

The bureau audits documentation, not marketing. COA authenticity, lab accreditation, claims-language risk, and regulatory history all feed the final determination. Here is what each check actually looks for.

Dr. Yuna Park

Lead Auditor · Medically reviewed: M. Osei, PharmD · 11 min read

Certificate of analysis documents spread on a review desk beside a magnifying glass — A certificate of analysis is only as useful as its chain of custody. The bureau traces each document to its issuing lab before any determination is made.

Verification Register

Full register (53) →

Vendor	Status	Last Audited	Score	Determination
Axis Researchaxisresearch.io	Verified	May 28, 2026	92	Audit file →
Helix Standardshelixstandards.com	Verified	Jun 1, 2026	84	Audit file →
Meridian Peptide Labmeridianpeptidelab.com	On Watch	May 19, 2026	61	Audit file →
Northwind Bionorthwindbio.com	On Watch	May 12, 2026	55	Audit file →
Verdant Labsverdantlabs.io	Failed	Apr 30, 2026	28	Audit file →
Apex Compoundsapexcompounds.com	Failed	Apr 14, 2026	19	Audit file →
CrestBio Researchcrestbioresearch.com	Pending	In queue	—	Audit open

Register covers research-compound vendors only. Determinations are educational, not regulatory. Peptides listed are not approved by FDA for human use. Scores updated within 48 hours of new evidence.

Audit Procedure

Full methodology →

Document Request

The bureau submits a standardized documentation request to the vendor. We ask for current COAs, lab accreditation certificates, regulatory disclosures, and refund policy documentation.

Opens audit record

Lab & COA Verification

Every certificate of analysis is traced back to the issuing laboratory. We confirm the lab holds relevant accreditation (ISO/IEC 17025 preferred) and that the batch number on the COA corresponds to a real, dated run.

9–14 days to complete

Claims & Regulatory Screen

Auditors review all public-facing copy — product pages, blog content, ads, and social accounts — for human-use, dosing, or treatment-outcome language. FDA warning-letter history is cross-referenced.

Ongoing monitoring

Determination & Publication

The lead auditor issues a status determination: Verified, On Watch, or Failed. The full audit record is published to the register with dated evidence. Vendors may file a documented appeal within 30 days.

Published within 48 hrs